This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Campina Nederland Holding B.v.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Alexander Wilhelmus Van Gessel: Innovator in Controlled Release Excipients
Introduction
Alexander Wilhelmus Van Gessel is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of controlled release excipients. His innovative work has led to the creation of a patent that enhances the effectiveness of slow or extended release tablets.
Latest Patents
Van Gessel holds a patent for an "Extended release excipient and its use." This patent describes a controlled release excipient composition that is suitable for formulating slow or extended release tablets. The composition includes a synergistic mixture of substantially uncross-linked carboxymethyl starch or sodium starch glycolate (SSG), along with a hydrophilic, non-ionic cellulose ether, preferably hydroxypropylmethylcellulose. The effectiveness of the SSG in the mixture can be determined by sedimentation tests, ensuring optimal performance in pharmaceutical applications.
Career Highlights
Van Gessel is associated with Campina Nederland Holding B.V., where he applies his expertise in excipient formulation. His work has been instrumental in advancing the field of controlled drug delivery systems. With a focus on improving patient outcomes, he continues to explore innovative solutions in pharmaceutical technology.
Collaborations
Some of his notable coworkers include Linqiu Cao and John Richard Langridge. Their collaborative efforts contribute to the ongoing research and development in the field of excipients and drug formulations.
Conclusion
Alexander Wilhelmus Van Gessel is a prominent figure in the realm of pharmaceutical innovations, particularly in controlled release excipients. His patent and contributions to the industry reflect his commitment to enhancing drug delivery systems. His work continues to influence the development of effective pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile